INDIGO Biosciences

About:

INDIGO Biosciences offers products and services on nuclear receptors, which comprise of therapeutic drug targets.

Website: http://indigobiosciences.com

Twitter/X: indigobio

Top Investors: Keiretsu Capital, Life Sciences Greenhouse of Pennsylvania, Broad Street Angels

Description:

INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.

Total Funding Amount:

$1.53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kelayres, Pennsylvania, United States

Founded Date:

2005-01-01

Contact Email:

customerserv(AT)indigobiosciences.com

Founders:

Blake Peterson, Jack Vanden Heuvel

Number of Employees:

11-50

Last Funding Date:

2018-02-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai